Raymond Richman - Jesse Richman - Howard Richman
Richmans' Trade and Taxes Blog
Winning the Trade War by Bringing the Right Weapon to Bear: Import Certificates
Under the Trump administration, the United States began to take measures to fight China's longstanding mercantilist practices. Trump and his advisors sought to use specific and targeted tariffs to bring China to the negotiating table and to bring about a revision of China's trade policy. China responded by upping the ante in its longstanding trade fight with the US, restricting US exports to China in ways targeted to inflict maximal pain on Trump's supporters. The end result by the end of the Trump administration was no resolution. The US had begun to resist China's longstanding mercantilist trade war, but China had not retreated from it at all. The Biden administration has made little progress to date on solving this problem, and it isn't clear it is even trying to solve it. In the meantime, China continues to use the industrial and financial might it has built in part on the strength of the enormous and enduring trade deficit with the United States to expand its reach as a global power. The current administration seems to have no viable route forward in mind, beyond the vain hope that conversation with China's leadership will bring about a favorable resolution.
But there is a viable path forward. That path involves the imposition of import certificates on China's exports to the US in order to force trade into balance. Import certificates are a perfect match for the problem of managing trade with China's nonmarket economy. They are also a principled response to China's mercantilism...
Head of Tokyo Medical Association recommends Ivermectin for COVID treatment
Dr. Haruo Ozaki, chairman of the Tokyo Medical Association, recommends ivermectin for use with COVID patients. He notes that the parts of Africa that use ivermectin to control parasites have a COVID death rate of just 2.2 per 100,000 population, as compared to 13 times that death rate among African countries that do not use ivermectin. Similarly, worldometer.com stats say that the COVID death rate in India (which uses HCQ and ivermectin to treat COVID) is 32 while the COVID death rate in the U.S.A. is 6.5 times higher at 205 per 100,000 population.
If these stats are accurate, then at least 6 of every 7 people who have died in the U.S. of COVID could be alive today had they been treated with ivermectin. Of course, ivermectin's effectiveness against COVID was not yet known when the first COVID wave hit the United States. Also, U.S. health statistics are notoriously inaccurate. Hospitals are given a financial incentive to identify almost everyone who dies with COVID as having died of COVID. Also, the first wave of COVID which hit the U.S. before it hit Africa and India was much more deadly than recent waves, simply because deadly viruses keep mutating into forms that spread more readily partly because they are less symptomatic and deadly.
In recent months, a growing number of American physicians have discovered that ivermectin works. But, according to The Last Refuge, President Biden's Department of Health and Human Services is taking steps, through the liability insurance system, to suppress the issuance of ivermectin prescriptions. Australia's federal government just banned physicians there from prescribing ivermectin to treat COVID.
Journal of Economic Literature:
Atlantic Economic Journal: